nodes	percent_of_prediction	percent_of_DWPC	metapath
Lornoxicam—PTGS1—breast cancer	0.406	0.636	CbGaD
Lornoxicam—PTGS2—breast cancer	0.232	0.364	CbGaD
Lornoxicam—CYP2C9—Anastrozole—breast cancer	0.0864	0.332	CbGbCtD
Lornoxicam—CYP2C9—Idarubicin—breast cancer	0.0655	0.252	CbGbCtD
Lornoxicam—CYP2C9—Capecitabine—breast cancer	0.0359	0.138	CbGbCtD
Lornoxicam—CYP2C9—Tamoxifen—breast cancer	0.0289	0.111	CbGbCtD
Lornoxicam—CYP2C9—Paclitaxel—breast cancer	0.0225	0.0863	CbGbCtD
Lornoxicam—CYP2C9—Fluorouracil—breast cancer	0.0213	0.0817	CbGbCtD
Lornoxicam—Tenoxicam—PTGS1—breast cancer	0.00128	0.228	CrCbGaD
Lornoxicam—Meloxicam—PTGS1—breast cancer	0.000909	0.162	CrCbGaD
Lornoxicam—Piroxicam—PTGS1—breast cancer	0.000788	0.141	CrCbGaD
Lornoxicam—Tenoxicam—PTGS2—breast cancer	0.000729	0.13	CrCbGaD
Lornoxicam—Meloxicam—CYP3A4—breast cancer	0.00053	0.0947	CrCbGaD
Lornoxicam—Meloxicam—PTGS2—breast cancer	0.000519	0.0927	CrCbGaD
Lornoxicam—Piroxicam—PTGS2—breast cancer	0.00045	0.0804	CrCbGaD
Lornoxicam—Piroxicam—ALB—breast cancer	0.000401	0.0716	CrCbGaD
Lornoxicam—CYP2C9—mammary gland—breast cancer	0.00026	0.084	CbGeAlD
Lornoxicam—PTGS1—nipple—breast cancer	0.000196	0.0634	CbGeAlD
Lornoxicam—PTGS2—embryo—breast cancer	0.000155	0.05	CbGeAlD
Lornoxicam—PTGS1—epithelium—breast cancer	0.000132	0.0427	CbGeAlD
Lornoxicam—PTGS2—epithelium—breast cancer	0.000126	0.0408	CbGeAlD
Lornoxicam—PTGS1—skin of body—breast cancer	0.000126	0.0406	CbGeAlD
Lornoxicam—PTGS2—skin of body—breast cancer	0.00012	0.0388	CbGeAlD
Lornoxicam—PTGS1—endometrium—breast cancer	0.000118	0.0383	CbGeAlD
Lornoxicam—PTGS2—endometrium—breast cancer	0.000113	0.0366	CbGeAlD
Lornoxicam—PTGS1—uterus—breast cancer	0.000109	0.0353	CbGeAlD
Lornoxicam—CYP2C9—female reproductive system—breast cancer	0.000107	0.0347	CbGeAlD
Lornoxicam—PTGS1—pituitary gland—breast cancer	0.000107	0.0347	CbGeAlD
Lornoxicam—PTGS1—adipose tissue—breast cancer	0.000107	0.0345	CbGeAlD
Lornoxicam—PTGS2—uterus—breast cancer	0.000104	0.0337	CbGeAlD
Lornoxicam—PTGS2—pituitary gland—breast cancer	0.000102	0.0331	CbGeAlD
Lornoxicam—PTGS2—adipose tissue—breast cancer	0.000102	0.033	CbGeAlD
Lornoxicam—PTGS1—female reproductive system—breast cancer	9.8e-05	0.0317	CbGeAlD
Lornoxicam—PTGS1—adrenal gland—breast cancer	9.57e-05	0.031	CbGeAlD
Lornoxicam—PTGS2—female reproductive system—breast cancer	9.37e-05	0.0303	CbGeAlD
Lornoxicam—PTGS2—adrenal gland—breast cancer	9.14e-05	0.0296	CbGeAlD
Lornoxicam—CYP2C9—endocrine gland—breast cancer	9.09e-05	0.0294	CbGeAlD
Lornoxicam—PTGS1—female gonad—breast cancer	8.92e-05	0.0289	CbGeAlD
Lornoxicam—PTGS2—bone marrow—breast cancer	8.85e-05	0.0286	CbGeAlD
Lornoxicam—PTGS2—female gonad—breast cancer	8.53e-05	0.0276	CbGeAlD
Lornoxicam—PTGS1—endocrine gland—breast cancer	8.3e-05	0.0268	CbGeAlD
Lornoxicam—PTGS2—endocrine gland—breast cancer	7.93e-05	0.0257	CbGeAlD
Lornoxicam—PTGS1—lymph node—breast cancer	5.74e-05	0.0186	CbGeAlD
Lornoxicam—PTGS2—lymph node—breast cancer	5.48e-05	0.0177	CbGeAlD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	2.22e-05	0.000239	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NCOA2—breast cancer	2.19e-05	0.000237	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—MED12—breast cancer	2.18e-05	0.000236	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—DPYD—breast cancer	2.18e-05	0.000236	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	2.18e-05	0.000235	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ALDH7A1—breast cancer	2.17e-05	0.000235	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ALDH1A1—breast cancer	2.17e-05	0.000235	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ENO1—breast cancer	2.16e-05	0.000233	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	2.15e-05	0.000232	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ALDOA—breast cancer	2.15e-05	0.000232	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—FASN—breast cancer	2.12e-05	0.00023	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—BCHE—breast cancer	2.12e-05	0.000229	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC5A5—breast cancer	2.09e-05	0.000226	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NCOA3—breast cancer	2.08e-05	0.000225	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—FHL2—breast cancer	2.08e-05	0.000225	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NME1—breast cancer	2.08e-05	0.000225	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ADSL—breast cancer	2.08e-05	0.000225	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—UMPS—breast cancer	2.08e-05	0.000225	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PHGDH—breast cancer	2.08e-05	0.000225	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC2A2—breast cancer	2.07e-05	0.000224	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.05e-05	0.000221	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—LDHB—breast cancer	2.04e-05	0.000221	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HPSE—breast cancer	2.04e-05	0.000221	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—BRIP1—breast cancer	2.04e-05	0.000221	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGF3—breast cancer	2.04e-05	0.00022	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CPT1A—breast cancer	2.03e-05	0.000219	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ABCG2—breast cancer	2.03e-05	0.000219	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—MTR—breast cancer	2.03e-05	0.000219	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC2A1—breast cancer	2.02e-05	0.000218	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NQO1—breast cancer	2.02e-05	0.000218	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—JAG1—breast cancer	2.01e-05	0.000218	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FASN—breast cancer	2.01e-05	0.000218	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PARP1—breast cancer	2.01e-05	0.000217	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—HPGDS—breast cancer	1.99e-05	0.000215	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CALCA—breast cancer	1.98e-05	0.000214	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.98e-05	0.000214	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—HBA1—breast cancer	1.98e-05	0.000213	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP3A4—breast cancer	1.97e-05	0.000213	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.96e-05	0.000212	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—RPS6—breast cancer	1.96e-05	0.000212	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGF4—breast cancer	1.94e-05	0.00021	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTA3—breast cancer	1.94e-05	0.000209	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HMMR—breast cancer	1.94e-05	0.000209	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ABCC1—breast cancer	1.94e-05	0.000209	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP1B1—breast cancer	1.94e-05	0.000209	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CXCR4—breast cancer	1.93e-05	0.000209	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ACHE—breast cancer	1.93e-05	0.000208	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTT1—breast cancer	1.93e-05	0.000208	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SLC2A1—breast cancer	1.91e-05	0.000207	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—HSP90AA1—breast cancer	1.9e-05	0.000205	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PPARGC1B—breast cancer	1.88e-05	0.000203	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.87e-05	0.000202	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TCF7L2—breast cancer	1.87e-05	0.000202	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NCOA1—breast cancer	1.85e-05	0.000199	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.83e-05	0.000197	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.83e-05	0.000197	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP17A1—breast cancer	1.82e-05	0.000197	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP19A1—breast cancer	1.82e-05	0.000197	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—STK11—breast cancer	1.82e-05	0.000197	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ENO1—breast cancer	1.81e-05	0.000195	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PTGS1—breast cancer	1.81e-05	0.000195	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.8e-05	0.000195	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HSP90AA1—breast cancer	1.8e-05	0.000194	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.78e-05	0.000192	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP2D6—breast cancer	1.77e-05	0.000191	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTA4—breast cancer	1.77e-05	0.000191	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CA9—breast cancer	1.77e-05	0.000191	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PRL—breast cancer	1.75e-05	0.000189	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.75e-05	0.000189	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NCOA2—breast cancer	1.74e-05	0.000188	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.73e-05	0.000187	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GPX2—breast cancer	1.73e-05	0.000187	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTA2—breast cancer	1.73e-05	0.000187	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ADAM10—breast cancer	1.72e-05	0.000186	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.71e-05	0.000185	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SULT1A1—breast cancer	1.7e-05	0.000184	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GPX4—breast cancer	1.7e-05	0.000184	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—COMT—breast cancer	1.69e-05	0.000183	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—FASN—breast cancer	1.69e-05	0.000182	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTP1—breast cancer	1.68e-05	0.000182	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—BCHE—breast cancer	1.68e-05	0.000182	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGF10—breast cancer	1.68e-05	0.000181	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—IDH1—breast cancer	1.67e-05	0.00018	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTA1—breast cancer	1.67e-05	0.00018	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—HMOX1—breast cancer	1.66e-05	0.000179	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC5A5—breast cancer	1.66e-05	0.000179	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ITPR1—breast cancer	1.66e-05	0.000179	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NAT2—breast cancer	1.65e-05	0.000178	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PDGFA—breast cancer	1.62e-05	0.000175	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NQO1—breast cancer	1.6e-05	0.000173	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC2A1—breast cancer	1.6e-05	0.000173	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TGFBR2—breast cancer	1.6e-05	0.000172	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ABCB1—breast cancer	1.59e-05	0.000172	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ITPR1—breast cancer	1.57e-05	0.00017	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.57e-05	0.00017	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—TYMS—breast cancer	1.56e-05	0.000169	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP3A4—breast cancer	1.56e-05	0.000169	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ERBB4—breast cancer	1.56e-05	0.000169	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—STAT5A—breast cancer	1.56e-05	0.000169	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NCOR1—breast cancer	1.55e-05	0.000167	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTM1—breast cancer	1.55e-05	0.000167	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PLA2G4A—breast cancer	1.55e-05	0.000167	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP1B1—breast cancer	1.54e-05	0.000166	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SMAD4—breast cancer	1.51e-05	0.000163	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—HSP90AA1—breast cancer	1.51e-05	0.000163	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.49e-05	0.000161	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GPX1—breast cancer	1.48e-05	0.00016	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HES1—breast cancer	1.47e-05	0.000159	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP1A1—breast cancer	1.47e-05	0.000158	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NCOR1—breast cancer	1.47e-05	0.000158	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NCOA1—breast cancer	1.47e-05	0.000158	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ERCC2—breast cancer	1.45e-05	0.000157	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGF1—breast cancer	1.45e-05	0.000157	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—STK11—breast cancer	1.44e-05	0.000156	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP19A1—breast cancer	1.44e-05	0.000156	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—DPYD—breast cancer	1.44e-05	0.000156	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MED12—breast cancer	1.44e-05	0.000156	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NRG1—breast cancer	1.44e-05	0.000156	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—H2AFX—breast cancer	1.43e-05	0.000154	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ALDOA—breast cancer	1.42e-05	0.000154	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NCOA3—breast cancer	1.38e-05	0.000149	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ERCC2—breast cancer	1.38e-05	0.000149	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC2A2—breast cancer	1.37e-05	0.000148	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—MTHFR—breast cancer	1.37e-05	0.000148	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.36e-05	0.000147	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.36e-05	0.000147	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ERBB3—breast cancer	1.35e-05	0.000146	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGFR2—breast cancer	1.35e-05	0.000145	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—COMT—breast cancer	1.34e-05	0.000145	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ABCG2—breast cancer	1.34e-05	0.000145	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CPT1A—breast cancer	1.34e-05	0.000145	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MTR—breast cancer	1.34e-05	0.000145	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTP1—breast cancer	1.34e-05	0.000144	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—HMOX1—breast cancer	1.32e-05	0.000142	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HPGDS—breast cancer	1.32e-05	0.000142	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ITPR1—breast cancer	1.31e-05	0.000142	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HBA1—breast cancer	1.31e-05	0.000141	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MTHFR—breast cancer	1.3e-05	0.00014	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TERT—breast cancer	1.29e-05	0.00014	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ACHE—breast cancer	1.28e-05	0.000138	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTT1—breast cancer	1.28e-05	0.000138	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ABCB1—breast cancer	1.26e-05	0.000137	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CAV1—breast cancer	1.26e-05	0.000136	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGFR1—breast cancer	1.25e-05	0.000136	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—TYMS—breast cancer	1.24e-05	0.000134	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HIF1A—breast cancer	1.24e-05	0.000134	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PLA2G4A—breast cancer	1.23e-05	0.000133	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTM1—breast cancer	1.23e-05	0.000133	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NCOR1—breast cancer	1.23e-05	0.000133	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP17A1—breast cancer	1.21e-05	0.000131	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.2e-05	0.00013	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ENO1—breast cancer	1.2e-05	0.000129	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTGS1—breast cancer	1.2e-05	0.000129	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CAV1—breast cancer	1.2e-05	0.000129	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.19e-05	0.000129	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.18e-05	0.000127	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GPX1—breast cancer	1.18e-05	0.000127	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP2D6—breast cancer	1.17e-05	0.000127	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP1A1—breast cancer	1.16e-05	0.000126	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ERCC2—breast cancer	1.15e-05	0.000125	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NCOA2—breast cancer	1.15e-05	0.000124	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3CG—breast cancer	1.15e-05	0.000124	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NOS2—breast cancer	1.12e-05	0.000121	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—FASN—breast cancer	1.12e-05	0.000121	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NOTCH1—breast cancer	1.11e-05	0.00012	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—BCHE—breast cancer	1.11e-05	0.00012	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC5A5—breast cancer	1.1e-05	0.000119	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—KIT—breast cancer	1.09e-05	0.000118	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—APC—breast cancer	1.09e-05	0.000118	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—MTHFR—breast cancer	1.09e-05	0.000117	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—EGF—breast cancer	1.08e-05	0.000116	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC2A1—breast cancer	1.06e-05	0.000115	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NQO1—breast cancer	1.06e-05	0.000115	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.04e-05	0.000112	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP3A4—breast cancer	1.03e-05	0.000112	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.03e-05	0.000111	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—BRAF—breast cancer	1.02e-05	0.000111	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP1B1—breast cancer	1.02e-05	0.00011	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3CD—breast cancer	1.01e-05	0.000109	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CAV1—breast cancer	1e-05	0.000108	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HSP90AA1—breast cancer	9.98e-06	0.000108	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ALB—breast cancer	9.97e-06	0.000108	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—AKT2—breast cancer	9.96e-06	0.000108	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NCOA1—breast cancer	9.7e-06	0.000105	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PIK3CD—breast cancer	9.57e-06	0.000103	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP19A1—breast cancer	9.56e-06	0.000103	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—STK11—breast cancer	9.56e-06	0.000103	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.56e-06	0.000103	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NOS3—breast cancer	9.54e-06	0.000103	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SERPINE1—breast cancer	9.47e-06	0.000102	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3CG—breast cancer	9.12e-06	9.85e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NOS3—breast cancer	9.04e-06	9.77e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	8.98e-06	9.7e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—COMT—breast cancer	8.89e-06	9.61e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTP1—breast cancer	8.85e-06	9.56e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3CB—breast cancer	8.8e-06	9.51e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HMOX1—breast cancer	8.73e-06	9.43e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTGS2—breast cancer	8.72e-06	9.42e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ITPR1—breast cancer	8.71e-06	9.41e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MDM2—breast cancer	8.58e-06	9.27e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—RAF1—breast cancer	8.55e-06	9.23e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ERBB2—breast cancer	8.45e-06	9.14e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ABCB1—breast cancer	8.38e-06	9.05e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MTOR—breast cancer	8.34e-06	9.02e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PIK3CB—breast cancer	8.34e-06	9.02e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CD4—breast cancer	8.33e-06	9e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—TYMS—breast cancer	8.23e-06	8.89e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTM1—breast cancer	8.13e-06	8.79e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PLA2G4A—breast cancer	8.13e-06	8.79e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NCOR1—breast cancer	8.13e-06	8.79e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3CD—breast cancer	8.02e-06	8.66e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ALB—breast cancer	7.91e-06	8.55e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CDKN1B—breast cancer	7.83e-06	8.46e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GPX1—breast cancer	7.79e-06	8.42e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP1A1—breast cancer	7.71e-06	8.33e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ERCC2—breast cancer	7.65e-06	8.26e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTEN—breast cancer	7.61e-06	8.22e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NOS3—breast cancer	7.57e-06	8.18e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CTNNB1—breast cancer	7.4e-06	7.99e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CDKN1A—breast cancer	7.23e-06	7.81e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PTEN—breast cancer	7.21e-06	7.79e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MTHFR—breast cancer	7.19e-06	7.77e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3CB—breast cancer	6.99e-06	7.55e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SRC—breast cancer	6.69e-06	7.23e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CAV1—breast cancer	6.63e-06	7.16e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—STAT3—breast cancer	6.45e-06	6.97e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.33e-06	6.84e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MAPK3—breast cancer	6.16e-06	6.66e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PIK3CG—breast cancer	6.04e-06	6.53e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PTEN—breast cancer	6.04e-06	6.52e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MYC—breast cancer	5.99e-06	6.47e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TGFB1—breast cancer	5.98e-06	6.46e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—EGFR—breast cancer	5.86e-06	6.33e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—KRAS—breast cancer	5.54e-06	5.98e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3CA—breast cancer	5.37e-06	5.8e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PIK3CD—breast cancer	5.31e-06	5.74e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ALB—breast cancer	5.24e-06	5.66e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PIK3CA—breast cancer	5.09e-06	5.5e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NOS3—breast cancer	5.01e-06	5.42e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HRAS—breast cancer	4.71e-06	5.09e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PIK3CB—breast cancer	4.63e-06	5e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTGS2—breast cancer	4.58e-06	4.95e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IL6—breast cancer	4.5e-06	4.87e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—AKT1—breast cancer	4.38e-06	4.74e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3CA—breast cancer	4.26e-06	4.6e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—AKT1—breast cancer	4.15e-06	4.49e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTEN—breast cancer	4e-06	4.32e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—AKT1—breast cancer	3.48e-06	3.76e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PIK3CA—breast cancer	2.82e-06	3.05e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—AKT1—breast cancer	2.3e-06	2.49e-05	CbGpPWpGaD
